Downregulation of PER2 increases Cyclin D and Cyclin E levels and increases the rate of tumor growth in breast cancer, disrupts DNA damage repair pathways and results in increased tumor growth (Fu et al., 2002; Xiang et al., 2008; Yang et al., 2009). Here, CCNE1 is linked to neoplasm.